Call Options

3 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q2 2018

Aug 10, 2018

SELL
$14.63 - $19.6 $5,852 - $7,840
-400 Closed
0 $0
Q1 2018

May 11, 2018

SELL
$17.23 - $20.35 $8,615 - $10,175
-500 Reduced 55.56%
400 $0
Q4 2017

Jan 17, 2018

BUY
$17.76 - $19.75 $15,984 - $17,775
900
900 $1,000

Others Institutions Holding AMPH

About Amphastar Pharmaceuticals, Inc.


  • Ticker AMPH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 49,015,200
  • Market Cap $1.64B
  • Description
  • Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and API. It offers Primatene Mist, an over-the-count...
More about AMPH
Track This Portfolio

Track Cutler Group LP Portfolio

Follow Cutler Group LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

News

Stay updated on Cutler Group LP with notifications on news.